Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Timothy C. Thompson, Styliani Karanika et al.|Science Signaling|2017Cited by 307
ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Timothy C. Thompson, Guang Yang et al.|Clinical Cancer Research|2021Cited by 145
Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate CancerYaoguang Zhang, Timothy C. Thompson, Bo Liu et al.|Clinical Cancer Research|2017Cited by 108
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Timothy C. Thompson, Theodoros Karantanos et al.|Cell Reports|2017Cited by 107
PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Timothy C. Thompson, Likun Li et al.|Clinical Cancer Research|2019Cited by 78